Page last updated: 2024-08-18

pyrazolanthrone and Crush Syndrome

pyrazolanthrone has been researched along with Crush Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cong, YX; Han, S; Huang, H; Lei, JL; Wang, H; Wang, PF; Zhang, BF; Zhuang, Y	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Crush Syndrome

Article	Year
Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway. Journal of orthopaedic surgery and research, 2017, Jul-12, Volume: 12, Issue:1 Topics: Animals; Anthracenes; Crush Syndrome; HMGB1 Protein; In Situ Nick-End Labeling; Kidney; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Muscle, Skeletal; Tumor Necrosis Factor-alpha	2017

Article

Year

Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway.

Journal of orthopaedic surgery and research, 2017, Jul-12, Volume: 12, Issue:1

Topics: Animals; Anthracenes; Crush Syndrome; HMGB1 Protein; In Situ Nick-End Labeling; Kidney; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Muscle, Skeletal; Tumor Necrosis Factor-alpha

2017